Search Results for “” – IFCC OSLM

OSLM

Outcome Studies
in Laboratory Medicine

guest

👤

Learn more about this platform

Categories:Observational

267 Publications found

Molecular-based targeted therapies in patients with hepatocellular carcinoma and hepato-cholangiocarcinoma refractory to atezolizumab/bevacizumab.

b

Journal of hepatology

December 1, 2023

p Cancer

c Change patient management Clinical Outcomes Observational
Clinical availability and characteristics of multigene panel testing for recurrent/advanced gynecologic cancer.

b

International journal of clinical oncology

November 1, 2023

p Cancer

c Change patient management Observational
A Retrospective Analysis of Biliary Tract Cancer Patients Presented to the Molecular Tumor Board at the Comprehensive Cancer Center Munich.

b

Targeted oncology

September 1, 2023

p Cancer

c Change patient management Clinical Outcomes Observational
Actionable molecular alterations in newly diagnosed and recurrent IDH1/2 wild-type glioblastoma patients and therapeutic implications: a large mono-institutional experience using extensive next-generation sequencing analysis.

b

European journal of cancer (Oxford, England : 1990)

September 1, 2023

p Cancer

c Change patient management Observational
First-Line Genomic Profiling in Previously Untreated Advanced Solid Tumors for Identification of Targeted Therapy Opportunities.

b

JAMA network open

July 3, 2023

p Cancer

c Change patient management Highlighted Observational
Molecular Tumor Board as a Clinical Tool for Converting Molecular Data Into Real-World Patient Care.

b

JCO precision oncology

July 1, 2023

p Cancer

c Change patient management Observational
Precision neuro-oncology: a pilot analysis of personalized treatment in recurrent glioma.

b

Journal of cancer research and clinical oncology

July 1, 2023

p Cancer

c Change patient management Clinical Outcomes Observational
Clinical utility of a regional precision medicine molecular tumor board and challenges to implementation.

b

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

July 1, 2023

p Cancer

c Change patient management Clinical Outcomes Observational
Smaller panel, similar results: genomic profiling and molecularly informed therapy in pancreatic cancer.

b

ESMO open

June 1, 2023

p Cancer

c Change patient management Clinical Outcomes Observational
Real-world outcomes among patients with EGFR-mutated non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors versus immunotherapy or chemotherapy in the first-line setting.

b

Cancer medicine

June 1, 2023

p Cancer

c Change patient management Clinical Outcomes Observational